Richard Stone

33PUBLICATIONS

219CO-AUTHORS

Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyMedical molecular engineering of nucleic acids and proteinsAdolescent health

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (33)

Sort by Publication Date:

|Jun 15, 2026

Prognostic and therapeutic implications of BRAF mutations in acute myeloid leukemia.

|May 26, 2026

Dual BCL-xL and BCL-2 Inhibition for Advanced Myeloid Neoplasms: A phase 1 dose-escalation study of Navitoclax, Venetoclax, and Decitabine.

|Nov 04, 2025

Correspondence on: Oral decitabine cedazuridine with and without venetoclax in higher-risk myelodysplastic syndromes or chronic myelomonocytic leukemia: a propensity score-matched study.

Luis E Aguirre, Richard M Stone, Daniel J DeAngelo

|Sep 30, 2025

Inotuzumab Ozogamicin Then Blinatumomab for Older Adults With Newly Diagnosed B-Cell ALL: Alliance Study A041703 Cohort 1 Results.

Matthew J Wieduwilt, Jun Yin, Oudom Kour

|Sep 19, 2025

Multi-dimensional analysis of adult acute myeloid leukemia cross-continents reveals age-associated trends in mutational landscape and treatment outcomes (Acute Myeloid Leukemia Cooperative Group & Alliance for Clinical Trials in Oncology).

Monica Cusan, Karilyn Larkin, Deedra Nicolet

|Feb 12, 2025

Acute Myeloid Leukemia: 2025 Update on Diagnosis, Risk-Stratification, and Management.

Shai Shimony, Maximilian Stahl, Richard M Stone

Pageof 6

Frequent Collaborators

Daniel J DeAngelo

Marlise R Luskin

Shai Shimony

Jacqueline S Garcia

Wendy Stock

Ann-Kathrin Eisfeld

Donna S Neuberg

Evan C Chen

Eric S Winer

Richard A Larson

Frequent Collaborators

Daniel J DeAngelo

Marlise R Luskin

Shai Shimony

Jacqueline S Garcia